AXA


First take: kickstarting the new year

03/05/24 -"Axa reported positive Q1 results, surpassing the consensus except for Solvency II. As it was a trading update, only the top-line indicators were provided, indicating sustained robust volume traction ..."

Pages
63
Language
English
Published on
03/05/24
You may also be interested by these reports :
17/05/24
Scor reported disappointing Q1 results, primarily due to the weak performance in the L&H segment. This was attributed to a negative experience ...

16/05/24
Aegon’s Q1 results were largely as expected, with OCG slightly under the consensus, indicating that the €1.1bn guidance may be conservative. Aegon ...

16/05/24
After reviewing the FY23 and Q1 results, and now fully incorporating the IFRS 17 standards, we have upgraded our recommendation from REDUCE to ADD ...

16/05/24
Ageas’s valuation appears rather appealing, especially when considering its growth profile and dominant presence in key markets such as Belgium. ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO